Generally, many patients may notice improvements in their blood sugar levels within a few weeks of beginning GLP-1 therapy
This drug is similar to Ozempic but is given at a higher dose, aiming to treat chronic obesity
1 Medications such as liraglutide, semaglutide, exenatide, and dulaglutide are classified as glucagon-like peptide-1 (GLP-1) receptor agonists that work by increasing glucose-dependent insulin secretion, slowing gastric emptying, and decreasing inappropriate glucagon secretion
Presented for research literature review only De Palo E et al
What makes VIOSs GLP-1 unique for weight management?VIOS Compounding Pharmacy2025-03-18T14:17:29+00:00 VIOS offers innovative GLP-1 that is tailored to individual dosage needs, promoting effective appetite control and weight management.
We adjust by indication and severity, not body mass